Framework Tirzepatide Review: Cost, Contradictory Pricing & Honest Verdict (2026)

This review independently confirmed a real pricing inconsistency on Framework's own site: different landing pages advertise different per-week rates for the same product — $19 on one, $25 on another, $75/month on a third — with no single page showing a consistent, dose-specific monthly price for tirzepatide. Every fact here comes from the company's own published program.

Genuinely contradictory pricing — confirmed directly

This is the most important thing to know about Framework before you sign up: this review independently confirmed that its own tirzepatide and semaglutide product pages carry no price at all. Instead, different landing pages advertise different weekly figures for "GLP-1s" generally — $19/week on one page and $25/week on another, plus a $75/month figure footnoted as a new-user-only promotion. A legacy page separately lists semaglutide at $349 per three months and tirzepatide at $549 per three months, also — none of these reconcile into one clear monthly rate. Get the actual price for your specific drug and dose in writing before committing.

What Framework is

Framework is a personalized-plan GLP-1 telehealth platform, offering compounded semaglutide and tirzepatide with doctor-guided treatment selection rather than a fixed product menu. It names its compounding pharmacy partner and uses US-licensed clinicians via a 503A pathway — a real transparency positive, if it can be independently confirmed given the pricing confusion elsewhere on the site.

The brand-vs-compounded question

Framework dispenses compounded tirzepatide only. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Framework's real strength is a named compounding pharmacy partner, rarer disclosure than most of this field offers, plus doctor-guided treatment selection rather than a fixed menu. The trade-off is significant and this review confirmed it directly: no clear, consistent price exists anywhere on the site for tirzepatide specifically — different pages show different weekly and quarterly figures that don't reconcile, and the drug-specific prices that do exist sit on what appears to be a legacy page. As with any GLP-1 program, and especially one with this much pricing inconsistency across its own pages, get your exact monthly cost confirmed in writing before committing to anything; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Framework's named pharmacy is a real positive, but this review directly confirmed genuinely contradictory pricing across the site's own pages — different weekly and quarterly figures that don't add up to one clear monthly rate for tirzepatide. Get your exact price in writing before committing anywhere on this platform. For providers with clear, single, dose-specific pricing this review has independently compare CoreAge Rx or FormidableMD. See our best tirzepatide providers ranking for the full field.